Chaperonology: The Third Eye on Brain Gliomas
AbstractThe European Organization for Research and Treatment of Cancer/National Cancer Institute of Canada Phase III trial has validated as a current regimen for high-grade gliomas (HGG) a maximal safe surgical resection followed by radiotherapy with concurrent temozolamide. However, it is essential to balance maximal tumor resection with preservation of the patient’s neurological functions. Important developments in the fields of pre-operative and intra-operative neuro-imaging and neuro-monitoring have ameliorated the survival rate and the quality of life for patients affected by HGG. Moreover, even though the natural history remains extremely poor, advancement in the molecular and genetic fields have opened up new potential frontiers in the management of this devastating brain disease. In this review, we aim to present a comprehensive account of the main current pre-operative, intra-operative and molecular approaches to HGG with particular attention to specific chaperones, also called heat shock proteins (Hsps), which represent potential novel biomarkers to detect and follow up HGG, and could also be therapeutic agents. View Full-Text
Share & Cite This Article
Graziano, F.; Bavisotto, C.C.; Gammazza, A.M.; Rappa, F.; de Macario, E.C.; Macario, A.J.L.; Cappello, F.; Campanella, C.; Maugeri, R.; Iacopino, D.G. Chaperonology: The Third Eye on Brain Gliomas. Brain Sci. 2018, 8, 110.
Graziano F, Bavisotto CC, Gammazza AM, Rappa F, de Macario EC, Macario AJL, Cappello F, Campanella C, Maugeri R, Iacopino DG. Chaperonology: The Third Eye on Brain Gliomas. Brain Sciences. 2018; 8(6):110.Chicago/Turabian Style
Graziano, Francesca; Bavisotto, C. C.; Gammazza, A. M.; Rappa, Francesca; de Macario, Everly C.; Macario, Albert J.L.; Cappello, Francesco; Campanella, Claudia; Maugeri, Rosario; Iacopino, Domenico G. 2018. "Chaperonology: The Third Eye on Brain Gliomas." Brain Sci. 8, no. 6: 110.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.